NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-197-2023-1-PC-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] PCT PCT PCT/US2023/069538 Expired
NCI E-129-2022-0-PC-01 CD25-SPECIFIC ANTIBODIES AND USES THEREOF PCT PCT PCT/US2023/069461 Expired
NIAID E-197-2023-1-US-04 ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF US ORD 18/345,478 Pending
NIAID E-197-2023-1-JP-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] JP National Stage 2025-500271 Pending
NIAID E-197-2023-0-JP-01 ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF JP National Stage 2025-500270 Pending
NCATS E-097-2023-0-US-01 POTENT AND SELECTIVE D3 ANTAGONISTS US 63/511,452 Expired
NEI E-076-2023-0-US-01 SHIPPING CONTAINER FOR SYSTEM SUPPORTING LIVE CELLS US 63/524,434 Expired
NIAID E-096-2023-0-US-01 NOVEL MALARIA VACCINE COMPRISING AMA1 AND RON2 ANTIGENS US 63/524,522 Expired
NCI E-520-2013-0-US-03 HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE US CON 18/344,242 12325731 Issued PDF
NIAID E-134-2020-1-US-01 ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS US National Stage 18/270,436 Pending
NCI E-150-2017-2-JP-02 Diagnostic Methods For T Cell Therapy JP DIV 2023-105613 Issued
NCI E-118-2024-0-PC-01 AUGMENTING MITOCHONDRIA IN IMMUNE CELLS FOR IMPROVED CANCER IMMUNOTHERAPY PCT PCT PCT/EP2023/067747 Expired
NINDS E-186-2023-0-US-01 Use of Iron Chelators for Treating Stuttering US 63/510,794 Expired
NCI E-132-2023-0-US-01 T CELL RECEPTORS TARGETING RAS WITH G12D, G12R, OR G12V MUTATION US 63/510,817 Expired
NCATS E-046-2021-0-IN-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF IN National Stage 202317043115 Pending
NCI E-158-2022-0-PC-01 IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE PCT PCT PCT/US2023/069057 Expired
NIAID E-055-2021-0-AU-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use AU National Stage 2022208035 Pending
NCI E-021-2023-0-US-01 PEPTIDE HYDROGEL COMPRISING HYDROPHILIC AZIDE-CONTAINING AMINO ACID AND
ITS USE 		US ORD 18/340,863 Pending
NCI E-171-2020-0-AU-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection AU National Stage 2021409956 Pending
NEI E-013-2021-0-AU-01 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE ENVIRONMENT AU National Stage 2021400321 Abandoned
NCATS E-047-2021-0-EP-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF EP National Stage 21912215.7 Pending
NEI E-293-2016-0-AU-01 TISSUE CLAMP AND IMPLANTATION METHOD AU DIV 2023203954 Issued
NCATS E-146-2022-0-PC-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2023/068897 Expired
NIBIB E-237-2020-0-EP-01 Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy EP National Stage 22737121.8 Abandoned
NCATS E-047-2021-0-BR-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF BR National Stage BR112023012586-3 Pending
NCI E-088-2020-0-HK-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION HK EP 62023074794.6 Pending
NCI E-171-2020-0-CN-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection CN National Stage 202180086835.1 Pending
NCATS E-047-2021-0-US-02 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US National Stage 18/258,586 Pending
NCI E-171-2020-0-US-02 EXO VII Inhibitor and Quinolone Antibiotic
Combination Useful for Treating Bacterial Infection 		US National Stage 18/268,603 Pending
NCATS E-047-2021-0-JP-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF JP National Stage 2023-537923 Pending
NCATS E-047-2021-0-IL-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF IL National Stage 303887 Pending
NHLBI E-134-2017-3-JP-01 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 JP DIV 2023-100171 Pending
NEI E-013-2021-0-CA-01 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE CA National Stage 3202729 Pending
NIAID E-001-2024-0-PC-01 Viral Strain Serology Assays PCT PCT PCT/US2023/068614 Expired
NEI E-013-2021-0-US-02 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE US National Stage 18/258,125 Pending
NCI E-202-2020-0-EP-01 TYROSYL-LOCK PEPTIDES EP National Stage 21840215.4 Pending
NIAID E-021-2021-0-EP-01 NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF EP National Stage 21830553.0 Pending
NCATS E-046-2021-0-US-02 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US National Stage 18/257,746 12534469 Issued PDF
NIAID E-031-2026-0-US-04 Antigenic Epstein Barr Virus Polypeptides US CON 18/335,893 12053503 Issued PDF
NCATS E-113-2023-0-PC-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2023/068520 Expired
NIBIB E-007-2021-0-CN-01 ANTIBODY SPECIFIC FOR SARS]COV]2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS CN National Stage 202180084270.3 Abandoned
NCATS E-046-2021-0-IL-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF IL National Stage 303709 Pending
NCI E-067-2017-0-CN-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES CN DIV 202310701331.7 Pending
NCATS E-046-2021-0-JP-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF JP National Stage 2023-535992 Pending
NCI E-089-2023-0-US-01 EPIDITHIODIKETOPIPERAZINE ANALOGS AND METHODS OF USE US 63/507,813 Expired
NIAID E-228-2016-1-IL-01 Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof IL DIV 303650 Issued
NIAAA E-110-2022-0-PC-01 METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES PCT PCT PCT/US2023/025047 Expired
NCI E-171-2020-0-CA-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection CA National Stage 3205044 Pending
NIAID E-055-2021-0-CA-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use CA National Stage 3205052 Pending
NCATS E-046-2021-0-MX-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF MX National Stage MX/a/2023/006937 Pending